Index of reports
> Cases with Febrile Neutropenia (261)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vincristine where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 261 Next >>
Possible Vincristine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Mantle Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Mantle Cell Lymphoma
Possible Vincristine side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-22
Patient: male
Reactions: Pneumonia Bacterial, Febrile Neutropenia
Drug(s) suspected as cause:
Cisplatin
Dosage: unk
Indication: Thymoma Malignant
Start date: 2011-08-01
Cyclophosphamide
Dosage: unk
Indication: Thymoma Malignant
Start date: 2011-08-01
Doxorubicin HCL
Dosage: unk
Indication: Thymoma Malignant
Start date: 2011-08-01
Vincristine
Dosage: unk
Indication: Thymoma Malignant
Start date: 2011-08-01
Possible Vincristine side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-21
Patient: 41 year old male
Reactions: Ecthyma, Pseudomonas Infection, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Prednisone TAB
Dosage: unk
Indication: B-Cell Lymphoma
Rituximab
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Vincristine side effects in male
Reported by a physician from India on 2012-08-17
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Gp2013
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-08-06
Blinded Mabthera
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-08-06
Blinded NO Treatment Received
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-08-06
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Prednisone TAB
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Vincristine side effects in male
Reported by a individual with unspecified qualification from United Kingdom on 2012-08-14
Patient: male, weighing 22.9 kg (50.4 pounds)
Reactions: Vomiting, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dactinomycin
Start date: 2012-07-04
End date: 2012-07-04
Doxorubicin Hydrochloride
Start date: 2012-07-04
End date: 2012-07-04
Doxorubicin Hydrochloride
Start date: 2012-07-05
End date: 2012-07-05
Ifex
Start date: 2012-07-04
End date: 2012-07-04
Ifex
Start date: 2012-07-05
End date: 2012-07-05
Mesnex
Start date: 2012-07-04
End date: 2012-07-04
Mesnex
Start date: 2012-07-06
End date: 2012-07-06
Mesnex
Start date: 2012-07-05
End date: 2012-07-05
Vincristine
Start date: 2012-07-04
End date: 2012-07-04
Vincristine
Start date: 2012-07-11
End date: 2012-07-11
Other drugs received by patient: Dexamethasone; Dexamethasone; Moviprep; Ondansetron; Cotrim; Docusate Sodium
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-09
Patient:
Reactions: Dermatitis Allergic, Pneumonia, Angina Pectoris, Febrile Neutropenia, Cognitive Disorder, Hepatitis, Arrhythmia, Interstitial Lung Disease, Gastrointestinal Disorder, Progressive Multifocal Leukoencephalopathy, Cardiac Failure Congestive, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient:
Reactions: Hospitalisation, Neuropathy Peripheral, Vomiting, Febrile Neutropenia, Neutropenia, Neutrophil Count Decreased, Lymphoma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: B-Cell Lymphoma
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: B-Cell Lymphoma
Prednisone
Dosage: for 5 days
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Radiotherapy
Indication: B-Cell Lymphoma
Rituximab
Indication: B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-08-07
Patient: male
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dasatinib
Dosage: one day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-26
Dexamethasone
Doxorubicin Hydrochloride
Methotrexate
Start date: 2012-05-11
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-03
Other drugs received by patient: Ondansetron; Glutamic Acid; Lorazepam; Morphine Sulfate; Bactrim
Possible Vincristine side effects in 41 year old male
Reported by a physician from Canada on 2012-08-03
Patient: 41 year old male
Reactions: Ecthyma, Diarrhoea, Pseudomonas Infection, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma Stage IV
Doxorubicin HCL
Indication: B-Cell Lymphoma Stage IV
Prednisone
Indication: B-Cell Lymphoma Stage IV
Rituximab
Indication: B-Cell Lymphoma Stage IV
Vincristine
Indication: B-Cell Lymphoma Stage IV
Other drugs received by patient: Epogen; Enoxaparin Sodium; Filgrastim
Possible Vincristine side effects in male
Reported by a lawyer from United States on 2012-08-03
Patient: male
Reactions: Tinnitus, Femur Fracture, Osteomyelitis, Oral Cavity Fistula, Erythema, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Oedema Peripheral, Carpal Tunnel Syndrome, Radiculopathy, Intervertebral Disc Protrusion, Cellulitis, Gingival Bleeding, Pneumonia, Pain in Extremity, Anaemia, Encephalopathy, Otitis Externa, Nasal Septum Deviation, Abscess JAW, Paraesthesia, Osteosclerosis, Rhinitis Allergic, Osteonecrosis, Mental Disorder, Osteoporosis, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Depression, Injury, Gastrooesophageal Reflux Disease, Pain in JAW, Dyspnoea, Spondylolysis, Spondylolisthesis, Hepatitis Acute, Musculoskeletal Pain, Febrile Neutropenia, Osteolysis, Cognitive Disorder, Deformity, Amnesia, Osteoarthritis, Anxiety, Osteonecrosis of JAW, Heart Rate Increased, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Clonazepam; Dexamethasone; Oxycontin; Tegretol; Neurontin
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-31
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Vincristine side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-30
Patient: female, weighing 49.0 kg (107.8 pounds)
Reactions: Death, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 71 mg, qdx5
Start date: 2010-11-25
End date: 2010-11-29
Clofarabine
Dosage: 71 mg, qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-11-01
End date: 2010-11-05
Oncaspar
Dosage: 3206.3 iu, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-11-01
End date: 2010-11-01
Oncaspar
Dosage: 3375 iu, unk
Start date: 2010-11-25
End date: 2010-11-25
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-11-25
End date: 2010-11-25
Other drugs received by patient: Itraconazole; Valaciclovir
Possible Vincristine side effects in male
Reported by a physician from United States on 2012-07-27
Patient: male
Reactions: Tinnitus, Femur Fracture, Oral Cavity Fistula, Osteomyelitis, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Carpal Tunnel Syndrome, Radiculopathy, Intervertebral Disc Protrusion, Cellulitis, Gingival Bleeding, Pneumonia, Anaemia, Encephalopathy, Otitis Externa, Abscess JAW, Nasal Septum Deviation, Paraesthesia, Rhinitis Allergic, Osteosclerosis, Osteonecrosis, Mental Disorder, Osteoporosis, Pain, Multiple Myeloma, Periodontitis, Neuropathy Peripheral, Overdose, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolysis, Hepatitis Acute, Spondylolisthesis, Febrile Neutropenia, Osteolysis, Cognitive Disorder, Amnesia, Deformity, Osteoarthritis, Anxiety, Osteonecrosis of JAW, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Clonazepam; Neurontin; Oxycontin; Tegretol; Dexamethasone
Possible Vincristine side effects in
Reported by a physician from Italy on 2012-07-27
Patient:
Reactions: Anaemia, Skin Toxicity, Febrile Neutropenia, Mucosal Inflammation, Neurotoxicity, Respiratory Failure, Sepsis, Neutropenia, Cardiotoxicity, Septic Shock, Thrombocytopenia, Myocardial Infarction, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Epirubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Prednisone and Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-26
Patient:
Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Chemoradiation
Indication: Hodgkin's Disease
Cyclophosphamide
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: as part of abvd or beacopp
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Prednisone
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vincristine
Indication: Hodgkin's Disease
Possible Vincristine side effects in 1 year old male
Reported by a physician from United States on 2012-07-25
Patient: 1 year old male
Reactions: Adenovirus Infection, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Start date: 2011-05-27
Lestaurtinib
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-27
Mercaptopurine
Start date: 2011-05-27
Methotrexate
Start date: 2011-05-27
Vincristine
Start date: 2011-05-27
Possible Vincristine side effects in female
Reported by a physician from Germany on 2012-07-24
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1493 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Doxorubicin Hydrochloride
Dosage: 100 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Pegfilgrastim
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-29
Prednisolone
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
End date: 2012-04-30
Rituximab
Dosage: 742.5 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-25
Vincristine
Dosage: 3.54 mg, q2wk
Indication: B-Cell Lymphoma
Start date: 2012-04-26
Other drugs received by patient: Ramipril; Trimethoprim; Levothyroxine / 00068002 /; Simvastatin; Enoxaparin Sodium; Acetylsalicylic Acid SRT; Acyclovir; Pantoprazole; Nebivolol; Torsemide; Tiotropium Bromide
Possible Vincristine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-23
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-04-26
Doxorubicin HCL
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Vincristine side effects in
Reported by a physician from Italy on 2012-07-20
Patient:
Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 100 mg on days 1-5 for chop and r-chop
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 375 mg/m2 on day 1 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Vincristine side effects in male
Reported by a lawyer from United States on 2012-07-20
Patient: male
Reactions: Femur Fracture, Tinnitus, Osteomyelitis, Oral Cavity Fistula, Erectile Dysfunction, Neurotoxicity, Hypoaesthesia Oral, Intervertebral Disc Protrusion, Cellulitis, Pneumonia, Anaemia, Otitis Externa, Abscess JAW, Nasal Septum Deviation, Paraesthesia, Osteonecrosis, Rhinitis Allergic, Mental Disorder, Pain, Multiple Myeloma, Periodontitis, Overdose, Neuropathy Peripheral, Intervertebral Disc Degeneration, Injury, Depression, Gastrooesophageal Reflux Disease, Pain in JAW, Spondylolysis, Spondylolisthesis, Hepatitis Acute, Febrile Neutropenia, Osteolysis, Deformity, Amnesia, Osteoarthritis, Osteonecrosis of JAW, Infection
Drug(s) suspected as cause:
Aredia
Thalidomide
Dosage: 50 mg, qd
Vincristine
Zometa
Dosage: 4 mg, qmo
Other drugs received by patient: Neurontin; Clonazepam; Oxycontin; Dexamethasone; Tegretol
Possible Vincristine side effects in 32 year old female
Reported by a physician from Belgium on 2012-07-19
Patient: 32 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1215 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
Doxorubicin HCL
Dosage: 81 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
End date: 2011-12-28
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-29
End date: 2011-12-29
Prednisone
Dosage: 500 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
Rituximab
Dosage: 608 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
End date: 2011-12-28
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-28
End date: 2011-12-28
Possible Vincristine side effects in female
Reported by a physician from United Kingdom on 2012-07-18
Patient: female, weighing 13.1 kg (28.8 pounds)
Reactions: Mucosal Inflammation, Candida Test Positive, Febrile Neutropenia, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: frequency: day 1, last dose prior to sae: 20/jun/2012
Indication: Sarcoma Metastatic
Cyclophosphamide
Dosage: last dose prior to sae 23/jun/2012
Administration route: Oral
Indication: Rhabdomyosarcoma
Start date: 2012-03-01
Dactinomycin
Dosage: frequency: day 1 of cycle dosage: 1.5 mg/m2 last dose prior to sae was taken on 30 aug 2011
Indication: Sarcoma Metastatic
Dactinomycin
Dosage: date of last dose prior to onset of sae: 11 oct 2011
Dactinomycin
Dosage: dosage: 1-5 mg/m2, day 1, date of last dose prior to sae: 23 nov 2011
Start date: 2011-07-12
Doxorubicin Hydrochloride
Dosage: frequency: days 1 and 2 dosage: 30 mg/m2 last dose prior to sae was taken on 31 aug 2011
Indication: Sarcoma Metastatic
Ifosfamide
Dosage: frequency: days 1 and 2. dosage form:3g/m2 last dose prior to sae was taken on 24 nov 2011
Indication: Sarcoma Metastatic
Mesna
Dosage: frequency: days 1 and 2 dosage form: 3600 mg/m2 last dose prior to sae was taken on 31 aug 2011
Indication: Sarcoma Metastatic
Mesna
Dosage: date of last dose prior to sae: 21 sep 2011
Mesna
Dosage: frequency: od, dosage form: 3600 mg/m2
Vincristine
Dosage: dosage cumm: 1.5 mg/m2, frequency days 1,8 and 15 of cyclelast doseprior to sae: 23 nov 2011
Indication: Sarcoma Metastatic
Vinorelbine Tartrate
Dosage: last dose prior to sae:20/jun/2012
Indication: Rhabdomyosarcoma
Start date: 2012-03-01
Other drugs received by patient: Ondansetron; Levomepromazine; Moviprep; Fluconazole; Levomepromazine; Cotrim; Docusate; Ondansetron; Gentamicin; Morphine; Moviprep; Neupogen; Neupogen; Dihydrocodeine Bitartrate INJ; Acetaminophen; Ondansetron; Docusate; Docusate; Piperacillin and Tazobactam; Moviprep; Emollient Cream (Unk Ingredients); Ondansetron
Possible Vincristine side effects in female
Reported by a physician from France on 2012-07-18
Patient: female, weighing 40.0 kg (88.0 pounds)
Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Istodax
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-12
Prednisone
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-10-27
End date: 2012-04-13
Possible Vincristine side effects in 83 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: 83 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Pneumocystis Jiroveci Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 400 mg/m2, cyclic, on day 1 of each cycle
Start date: 2010-10-15
Cyclophosphamide
Dosage: 400 mg/m2, single (cycle 5)
Start date: 2011-01-13
Doxorubicin HCL
Dosage: 25 mg/m2, cyclic, on day 1 of each cycle
Start date: 2010-10-15
Doxorubicin HCL
Dosage: 25 mg/m2, single (cycle 5)
Start date: 2011-01-13
Mabthera
Dosage: 375 mg/m2, single (cycle 5)
Start date: 2011-01-13
Mabthera
Dosage: 375 mg/m2, cyclic, one day 1 of each cycle
Start date: 2010-10-15
Prednisone
Dosage: 40 mg/m2, cyclic, from day 1 to day 4 of each cycle
Administration route: Oral
Start date: 2010-10-15
Prednisone
Dosage: 40 mg/m2, 1x/day (cycle 5)
Administration route: Oral
Start date: 2011-01-13
End date: 2011-01-17
Vincristine
Dosage: 1 mg/m2, cyclic, on day 1 of each cycle
Start date: 2010-10-15
Vincristine
Dosage: 1 mg/m2, single (cycle 5)
Start date: 2011-01-13
Other drugs received by patient: Nexium
Possible Vincristine side effects in
Reported by a physician from United States on 2012-07-16
Patient:
Reactions: Fatigue, Febrile Neutropenia, Peripheral Motor Neuropathy, Peripheral Sensory Neuropathy, Arrhythmia, Cerebral Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Possible Vincristine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient:
Reactions: Bacteraemia, Febrile Neutropenia, Haematotoxicity
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Cytarabine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Dexamethasone
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Mabthera
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Methotrexate
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Vincristine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Possible Vincristine side effects in 61 year old male
Reported by a consumer/non-health professional from Germany on 2012-07-13
Patient: 61 year old male
Reactions: Candida Pneumonia, Bronchopneumonia, Febrile Neutropenia, Respiratory Distress, Organising Pneumonia, Respiratory Failure, Interstitial Lung Disease, Pseudomonal Sepsis, Opportunistic Infection, Stenotrophomonas Sepsis, Tracheitis, Septic Shock, Sinusitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, qd
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-08
Campath
Dosage: 30 mg, qd
Start date: 2010-02-22
End date: 2010-02-23
Cyclophosphamide
Dosage: 1380 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Cyclophosphamide
Dosage: 690 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Doxorubicin HCL
Dosage: 92 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Doxorubicin HCL
Dosage: 46 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Pegfilgrastim
Dosage: 6 mg, qd
Start date: 2010-03-01
End date: 2010-03-01
Pegfilgrastim
Dosage: 3 mg, qd
Indication: T-Cell Lymphoma
Posaconazole
Indication: Prophylaxis
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2010-02-22
End date: 2010-02-26
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-11
Vincristine
Dosage: 2 mg, unk
Start date: 2010-02-22
End date: 2010-02-22
Vincristine
Dosage: 2 mg, unk
Indication: T-Cell Lymphoma
Start date: 2010-01-07
End date: 2010-01-07
Possible Vincristine side effects in
Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13
Patient:
Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Dexamethasone
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Prophylaxis
Prednisone
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Possible Vincristine side effects in female
Reported by a physician from Malaysia on 2012-07-11
Patient: female, weighing 66.8 kg (147.0 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Gp2013
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Blinded Mabthera
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Blinded NO Treatment Received
Dosage: code not broken
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Cyclophosphamide
Dosage: 125 mg, qd
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Prednisolone
Dosage: 100 mg, qd
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Vincristine
Dosage: 2 mg, qd
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Other drugs received by patient: Allopurinol
Page 1 Next >>
|